EASL-EASD-EASO 2024 Clinical Practice Guidelines on MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Zusammenfassung

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) q European Association for the Study of the Liver (EASL)*, European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO) Summary Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one

Kerninformationen

Published by Elsevier BV on behalf of European Association for the Study of the Liver (EASL) and by S Karger AG. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) h...

These guidelines were developed by the European Association for the Study of the Liver (EASL), the European Association for the Study of Diabetes (EASD), and the European Association for the Study of Obesity and jointly published in the Journal of Hepatology and Obesity Facts. The articles are ident...

Thus, users should adapt the recommendations to their local regulations, availability of resources, infrastructure, and cost-benefit strategies. Preamble The nomenclature of SLD and definition of MASLD were established in June 2023, following an international, multi- society guided Delphi process. 2...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen